Ethyl Bromo Acetate

Ethyl Bromo Acetate

SCHEMBL30029142

CCOC(=O)CBr.CCOC(=O)CN1C2CCC1CC(C(=O)OCC)C2

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.47
TRPA1 O75762 1/20 0.47
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
MAPT P10636 2/20 0.38
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
POLB P06746 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 2/20 0.34
ABL1 P00519 1/20 0.33
RIN1 Q13671 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Bromo Acetate SCHEMBL30029347 0.95 ALDH1A1 (0.45) ALDH1A1TRPA1MEN1KMT2AMAPT
SCHEMBL30028689 0.93 MEN1 (0.43) ALDH1A1MEN1KMT2AMAPTCYP3A4
Ethyl Bromo Acetate SCHEMBL30028633 0.88 ALDH1A1 (0.44) ALDH1A1TRPA1MEN1KMT2AMAPT
SCHEMBL8912197 0.87 KMT2A (0.45) ALDH1A1MEN1KMT2AMAPTCYP3A4
SCHEMBL5114769 0.82 MEN1 (0.40) ALDH1A1MEN1KMT2AMAPTCYP3A4
SCHEMBL8912207 0.80 MEN1 (0.38) ALDH1A1MEN1KMT2AMAPTCYP3A4
SCHEMBL5121809 0.79 GSK3A (0.40) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL9698278 0.75 ENPP2 (0.38) ALDH1A1KMT2APOLBSMN1; SMN2KDM4E
SCHEMBL14014876 0.75 MEN1 (0.33) ALDH1A1MEN1KMT2AMAPTCYP3A4
SCHEMBL5653075 0.74 ALDH1A1 (0.39) ALDH1A1MEN1KMT2APOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022175402-A1 QUINUCLIDINE-3-ONE DERIVATIVES APREA THERAPEUTICS AB (SE) 2022-08-25 WO disclosed